Details for Patent: 8,269,040
✉ Email this page to a colleague
Which drugs does patent 8,269,040 protect, and when does it expire?
Patent 8,269,040 protects PRISTIQ and is included in one NDA.
This patent has twenty-two patent family members in sixteen countries.
Summary for Patent: 8,269,040
| Title: | Derivatives of venlafaxine and methods of preparing and using the same |
| Abstract: | Methods of preparing, and compositions comprising, derivatives of venlafaxine are disclosed. Also disclosed are methods of treating and preventing diseases and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders. |
| Inventor(s): | Jerussi; Thomas P. (Framingham, MA), Senanayake; Chrisantha H. (Shrewsbury, MA), Bhongle; Nandkumar N. (Shrewsbury, MA) |
| Assignee: | Wyeth LLC (Madison, NJ) |
| Application Number: | 10/720,134 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,269,040 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 8,269,040
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-003 | Aug 20, 2014 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-001 | Feb 29, 2008 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-002 | Feb 29, 2008 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,269,040
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 397581 | ⤷ Try a Trial | |||
| Australia | 2005218047 | ⤷ Try a Trial | |||
| Australia | 4062700 | ⤷ Try a Trial | |||
| Australia | 782092 | ⤷ Try a Trial | |||
| Canada | 2368083 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
